Amanote Research
Register
Sign In
Discover open access scientific publications
Search, annotate, share and cite publications
Publications by Farshid Dayyani
Retrospective Analysis of Survival Outcomes and the Role of Cisplatin-Based Chemotherapy in Patients With Urethral Carcinomas Referred to Medical Oncologists
Urologic Oncology: Seminars and Original Investigations
Oncology
Urology
Combined Inhibition of IGF-1R/IR and SRC Family Kinases Enhances Antitumor Effects in Prostate Cancer by Decreasing Activated Survival Pathways
PLoS ONE
Multidisciplinary
Related publications
Increased CD70 Expression Is Associated With Clinical Resistance to Cisplatin-Based Chemotherapy and Poor Survival in Advanced Ovarian Carcinomas
OncoTargets and Therapy
Oncology
Pharmacology
Efficacy of Fluoropyrimidine-Based Chemotherapy in Patients With Advanced Biliary Tract Cancer After Failure of Gemcitabine Plus Cisplatin: Retrospective Analysis of 321 Patients
British Journal of Cancer
Cancer Research
Oncology
Retrospective Analysis of Clinical Outcomes With Neoadjuvant Cisplatin-Based Regimens for Muscle-Invasive Bladder Cancer
Clinical Genitourinary Cancer
Oncology
Urology
Clinical Outcomes With Perioperative Chemotherapy in Sarcomatoid Carcinomas of the Lung
Journal of Thoracic Oncology
Medicine
Oncology
Respiratory Medicine
Pulmonary
Retrospective Analysis of Patients Referred for Arteriovenous Fistula Formation
European Journal of Vascular and Endovascular Surgery
Surgery
Cardiovascular Medicine
Cardiology
Choosing Chemotherapy in Patients With Advanced Urothelial Cell Cancer Who Are Unfit to Receive Cisplatin-Based Chemotherapy
Therapeutic Advances in Medical Oncology
Oncology
The Impact of Cisplatin‐ or Non‐Cisplatin‐Containing Chemotherapy on Long‐Term and Conditional Survival of Patients With Advanced Urinary Tract Cancer
Oncologist
Cancer Research
Medicine
Oncology
A Retrospective Study of Palliative Cisplatin-Based Doublet Chemotherapy for Malignant Pleural Mesothelioma
Cancer and Clinical Oncology
Survival Analysis of Adjuvant Chemotherapy With S-1 Plus Cisplatin for Stage III Gastric Cancer
Gastric Cancer
Cancer Research
Medicine
Oncology
Gastroenterology